RSS
UCL
Modified form of botulinum toxin could replace opioids, notes new research
New research from UCL, the University of Sheffield and the Hospital for Sick Children, Toronto, has highlighted that a modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects Read more
University fund makes £1m investment in gene therapy
The University College London Technology Fund has announced an investment of up to £1 million for the development of gene therapies Read more
BBRSC Programme Combines Chemistry and Biochemical Engineering at UCL
The Almac biocatalysis group has secured a prestigious BBSRC (Biotechnology and Biological Sciences Research Council) programme with UCL focused specifically on metagenomics and novel enzyme discovery. Read more
